Precave: Immediate neoadjuvant instillation of chemotherapy for the prevention of non-muscle invasive bladder carcinoma recurrence: A prospective randomized clinical trial protocol

INTRODUCTION AND OBJECTIVES: Recurrence rates for patients presenting with non-muscle invasive bladder carcinoma (NMIBC) can be as high as 60% during the first year after a transurethral resection of bladder tumor (TURBT). Currently, an immediate postoperative instillation of chemotherapy (IPOIC) is...

Descripción completa

Detalles Bibliográficos
Autores principales: Carrion, Diego M., Gómez Rivas, Juan, Ballesteros Ruiz, Cristina, Alvarez-Maestro, Mario, Aguilera Bazán, Alfredo, Martínez-Piñeiro, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644741/
https://www.ncbi.nlm.nih.gov/pubmed/33195885
http://dx.doi.org/10.1016/j.isjp.2020.10.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644741/
https://www.ncbi.nlm.nih.gov/pubmed/33195885
http://dx.doi.org/10.1016/j.isjp.2020.10.001

Ejemplares similares